Market Closed -
Other stock markets
|
Pre-market 09:29:03 am | |||
51.74 USD | +0.21% | 51.54 | -0.38% |
Apr. 24 | Oppenheimer Adjusts Incyte Price Target to $84 From $92, Maintains Outperform Rating | MT |
Apr. 23 | Transcript : Escient Pharmaceuticals, Inc., Incyte Corporation - M&A Call |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation